Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

'Movember' cash to help prostate cancer research

  • Comment

Money raised by men growing moustaches is to pay for a £10m “centres of excellence” programme aimed at boosting research into prostate cancer.

The money will fund two dedicated research “hubs” in the UK bringing together experts from across different disciplines.

Using existing facilities, one will join laboratories in Belfast and Manchester while the other will be centred in London.

The Movember Foundation launched the programme in partnership with leading charity Prostate Cancer UK.

Movember challenges men to grow a moustache for the 30-days of November to raise money for men’s health.

Sara Coghlan, from the charity, said: “Launching the Movember Centres of Excellence is one of the most significant and exciting milestones in the Movember Foundation’s history to date.

“Aligned with our focus on collaboration and working closely with our partner Prostate Cancer UK, we’re bringing the best in the research world together for a sustained period to have a real impact and to develop real understanding of how to fight this disease.

“These Movember Centres of Excellence are the first of their kind in the UK focussed on prostate cancer, and they represent the Movember Foundation’s commitment to having an everlasting impact on the face of men’s health.”

The £10m funding will be made available over five years and represents the biggest single investment by the Movember - Prostate Cancer UK partnership to date.

Dr Iain Frame, director of research at Prostate Cancer UK said: “It is staggering to consider what we still don’t know about prostate cancer today, despite it being the most common cancer in men.

“Our Centres programme is a game-changer. By bringing the key minds in prostate cancer research together, and supporting international collaboration, these world class hubs will catalyse innovation and discovery, their impact set to be far greater than the sum of their parts.

“They will also provide a world-class training ground for the scientists of the future, building a legacy of top prostate cancer researchers in the UK and representing lasting hope for those who are affected by the disease now and for years to come.”

Each year around 40,000 men in the UK are diagnosed with prostate cancer and 11,000 die from the disease.

Professor Richard Marais, from the University of Manchester, said: “This is very exciting for the future of prostate cancer research.

“We have established a unique collaboration that will bring together knowledge and insights from across different cancers and disciplines, which will enable us to tackle some of the complexities still surrounding this disease from a new perspective.

“Crucially, by working in partnership we also hope to increase the speed at which lab breakthroughs reach the man in the clinic and have a direct impact on patient outcomes.”

Are you able to Speak out Safely?

Sign our petition to put pressure on your trust to support an open and transparent NHS

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.